Vogelbaum MA, Brown PD, Messersmith H et al (2021) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. https://doi.org/10.1200/JCO.21.02314

Article  PubMed  Google Scholar 

Gondi V, Bauman G, Bradfield L et al (2022) Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol. https://doi.org/10.1016/j.prro.2022.02.003

Article  PubMed  Google Scholar 

Ramakrishna N, Anders CK, Lin NU et al (2022) Management of advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: ASCO guideline update. J Clin Oncol 40:2636–2655. https://doi.org/10.1200/JCO.22.00520

CAS  Article  PubMed  Google Scholar 

Magnuson WJ, Lester-Coll NH, Wu AJ et al (2017) Management of brain metastases in tyrosine kinase inhibitor-naïve epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis. J Clin Oncol 35:1070–1077. https://doi.org/10.1200/JCO.2016.69.7144

CAS  Article  PubMed  Google Scholar 

Dai L, Luo C-Y, Hu G-X et al (2020) Comparative analysis of first-line treatment regimens for advanced EGFR-mutant non-small cell lung cancer patients with stable brain metastases. Ann Palliat Med 9:2062–2071. https://doi.org/10.21037/apm-20-1136

Article  PubMed  Google Scholar 

Reungwetwattana T, Nakagawa K, Cho BC et al (2018) CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer. J Clin Oncol. https://doi.org/10.1200/JCO.2018.78.3118

Article  PubMed  Google Scholar 

Zhang Z, Guo H, Lu Y et al (2019) Anaplastic lymphoma kinase inhibitors in non-small cell lung cancer patients with brain metastases a meta-analysis. J Thorac Dis 11:1397–1409. https://doi.org/10.21037/jtd.2019.03.76

CAS  Article  PubMed  PubMed Central  Google Scholar 

Murthy RK, Loi S, Okines A et al (2020) Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer. N Engl J Med 382:597–609. https://doi.org/10.1056/NEJMoa1914609

CAS  Article  PubMed  Google Scholar 

Gori S, Puglisi F, Moroso S et al (2019) The HERBA study: a retrospective multi-institutional Italian study on patients with brain metastases from HER2-positive breast cancer. Clin Breast Cancer 19:e501–e510. https://doi.org/10.1016/j.clbc.2019.05.006

Article  PubMed  Google Scholar 

Lin NU, Pegram M, Sahebjam S et al (2021) Pertuzumab plus high-dose trastuzumab in patients with progressive brain metastases and HER2-positive metastatic breast cancer: primary analysis of a phase II study. J Clin Oncol 39:2667–2675. https://doi.org/10.1200/JCO.20.02822

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bailleux C, Eberst L, Bachelot T (2021) Treatment strategies for breast cancer brain metastases. Br J Cancer 124:142–155. https://doi.org/10.1038/s41416-020-01175-y

Article  PubMed  Google Scholar 

Long GV, Atkinson V, Lo S et al (2018) Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol 5877:579. https://doi.org/10.1016/S1470-2045(18)30139-6

Article  Google Scholar 

Zhou Y, Wang B, Qu J et al (2020) Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: osimertinib vs. first-generation EGFR tyrosine kinase inhibitors. Lung Cancer 150:178–185. https://doi.org/10.1016/j.lungcan.2020.10.018

Article  PubMed  Google Scholar 

Petrelli F, Ghidini M, Lonati V et al (2017) The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: a systematic review and pooled analysis. Eur J Cancer 84:141–148. https://doi.org/10.1016/j.ejca.2017.07.024

CAS  Article  PubMed  Google Scholar 

Bachelot T, Romieu G, Campone M et al (2013) Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. Lancet Oncol 14:64–71. https://doi.org/10.1016/S1470-2045(12)70432-1

CAS  Article  PubMed  Google Scholar 

Saura C, Oliveira M, Feng Y-H et al (2020) Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: phase III NALA trial. J Clin Oncol 38:3138–3149. https://doi.org/10.1200/JCO.20.00147

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lin NU, Borges V, Anders C et al (2020) Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial. J Clin Oncol 38:2610–2619. https://doi.org/10.1200/JCO.20.00775

CAS  Article  PubMed  PubMed Central  Google Scholar 

Krop IE, Lin NU, Blackwell K et al (2015) Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA. Ann Oncol 26:113–119. https://doi.org/10.1093/annonc/mdu486

CAS  Article  PubMed  Google Scholar 

Modi S, Saura C, Yamashita T et al (2020) Trastuzumab deruxtecan in previously treated HER2-positive breast cancer. N Engl J Med 382:610–621. https://doi.org/10.1056/NEJMoa1914510

CAS  Article  PubMed  Google Scholar 

Tonse R, Tom MC, Mehta MP et al (2021) Integration of systemic therapy and stereotactic radiosurgery for brain metastases. Cancers. https://doi.org/10.3390/cancers13153682

Article  PubMed  PubMed Central  Google Scholar 

Suh JH, Kotecha R, Chao ST et al (2020) Current approaches to the management of brain metastases. Nat Rev Clin Oncol 17:279–299. https://doi.org/10.1038/s41571-019-0320-3

Article  PubMed  Google Scholar 

Gamboa-Vignolle C, Ferrari-Carballo T, Arrieta Ó, Mohar A (2012) Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial. Radiother Oncol 102:187–191. https://doi.org/10.1016/j.radonc.2011.12.004

CAS  Article  PubMed  Google Scholar 

Liu H-P, Zheng K-B, Wang J-W (2017) Efficacy and safety of temozolomide plus whole-brain radiotherapy in the treatment of intracranial metastases. J Cancer Res Ther 13:785. https://doi.org/10.4103/jcrt.JCRT_323_17

CAS  Article  PubMed  Google Scholar 

Schapira E, Hubbeling H, Yeap BY et al (2018) Improved overall survival and locoregional disease control with concurrent PD-1 pathway inhibitors and stereotactic radiosurgery for lung cancer patients with brain metastases. Int J Radiati Oncol*Biol*Phys 101:624–629. https://doi.org/10.1016/j.ijrobp.2018.02.175

Article  Google Scholar 

Borius P-Y, Régis J, Carpentier A et al (2021) Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review. Cancer Metastasis Rev 40:341–354. https://doi.org/10.1007/s10555-020-09949-9

Article  PubMed  Google Scholar 

Ramakrishna R, Formenti S (2019) Radiosurgery and immunotherapy in the treatment of brain metastases. World Neurosurg 130:615–622. https://doi.org/10.1016/j.wneu.2019.04.032

Article  PubMed  Google Scholar 

Kraft J, van Timmeren JE, Frei S et al (2022) Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective. Radiother Oncol. https://doi.org/10.1016/j.radonc.2022.04.024

Article  PubMed  Google Scholar 

Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16:e270–e278. https://doi.org/10.1016/S1470-2045(15)70057-4

Article  PubMed  Google Scholar 

Zhu J, Sharma DB, Gray SW et al (2012) Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA 307:1593–1601. https://doi.org/10.1001/jama.2012.454

CAS  Article  PubMed  PubMed Central  Google Scholar 

Takekuma M, Takahashi F, Mabuchi S et al (2020) Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy. BMC Cancer 20:1169. https://doi.org/10.1186/s12885-020-07672-w

CAS  Article  PubMed  PubMed Central  Google Scholar 

Sperduto PW, De B, Li J et al (2022) Graded prognostic assessment (GPA) for patients with lung cancer and brain metastases: initial report of the small cell lung cancer GPA and update of the non-small cell lung cancer GPA including the effect of programmed death ligand 1 and other prognostic factors. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2022.03.020

Article  PubMed  Google Scholar 

Sperduto PW, Mesko S, Li J et al (2020) Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of THE eligibility quotient. J Clin Oncol 38:3773–3784. https://doi.org/10.1200/JCO.20.01255

CAS  Article  PubMed  PubMed Central  Google Scholar 

Patrikidou A, Chaigneau L, Isambert N et al (2020) Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). BMC Cancer 20:117. https://doi.org/10.1186/s12885-020-6548-6

Article  PubMed  PubMed Central  Google Scholar 

Geraud A, Xu HP, Beuzeboc P, Kirova YM (2017) Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer. J Neurooncol 131:69–72. https://doi.org/10.1007/s11060-016-2265-z

CAS  Article  PubMed  Google Scholar 

Hatten SJ Jr, Lehrer EJ, Liao J et al (2022) A patient-level data meta-analysis of the abscopal effect. Adv Radiat Oncol 7:100909. https://doi.org/10.1016/j.adro.2022.100909

Article  PubMed  PubMed Central  Google Scholar 

Lin X, Lu T, Xie Z et al (2019) Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: a case report and literature review. Thorac Cancer 10:1272–1275. https://doi.org/10.1111/1759-7714.13048

Article